glp-1 safe to use Medications Infographic Study: Most Patients Can Safely

Description

CrossRef Extracellular Vesicles as Carriers of Adipokines and Their Role in Obesity Tamara Camino, Nerea Lago-Baameiro, Mara Pardo Biomedicines.2023

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI (1993) Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

El GLP-1 ha servido de desarrollo de toda una familia farmacolgica (los arGLP-1), mientras que el GIP no ha conducido a un desarrollo similar, probablemente porque sus efectos insulinotrpicos estn alterados en las personas con DM2, a pesar de que los efectos insulinotrpicos del GIP pueden ser restaurados tras 4 semanas de normalizacin de la hiperglucemia con insulina en pacientes con DM2

However, when patients with NAFLD also have type 2 diabetes or meet criteria for weight management therapy, GLP-1 agonists prescribed for these licensed indications may confer additional hepatic benefits